Macrogenics (MGNX) Cash from Investing Activities (2016 - 2025)
Macrogenics (MGNX) has disclosed Cash from Investing Activities for 14 consecutive years, with -$66.0 million as the latest value for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 259.14% to -$66.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$114.1 million, a 176.42% decrease, with the full-year FY2025 number at -$114.1 million, down 176.42% from a year prior.
- Cash from Investing Activities was -$66.0 million for Q4 2025 at Macrogenics, down from -$20.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $71.9 million in Q3 2022 to a low of -$113.5 million in Q2 2023.
- A 5-year average of -$538900.0 and a median of $3.6 million in 2021 define the central range for Cash from Investing Activities.
- Peak YoY movement for Cash from Investing Activities: surged 2849.18% in 2022, then crashed 592.54% in 2023.
- Macrogenics' Cash from Investing Activities stood at -$13.6 million in 2021, then surged by 57.29% to -$5.8 million in 2022, then soared by 770.73% to $38.8 million in 2023, then grew by 6.81% to $41.5 million in 2024, then plummeted by 259.14% to -$66.0 million in 2025.
- Per Business Quant, the three most recent readings for MGNX's Cash from Investing Activities are -$66.0 million (Q4 2025), -$20.4 million (Q3 2025), and -$37.6 million (Q2 2025).